Loading…
Cibus, Inc. is projected to decline to $1.41 by 2027, a -6% move from its current price of $1.50. CBUS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.43 | $1.50 | $1.57 | -0.03% |
| May 30 | $1.40 | $1.50 | $1.60 | -0.07% |
| May 31 | $1.38 | $1.50 | $1.63 | -0.10% |
| Jun 1 | $1.36 | $1.50 | $1.65 | -0.13% |
| Jun 2 | $1.34 | $1.50 | $1.67 | -0.17% |
| Jun 3 | $1.33 | $1.50 | $1.69 | -0.20% |
| Jun 4 | $1.32 | $1.50 | $1.70 | -0.23% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.32 | $1.50 | $1.70 | -0.23% |
| Week 2 | $1.25 | $1.49 | $1.79 | -0.46% |
| Week 3 | $1.19 | $1.49 | $1.86 | -0.70% |
| Week 4 | $1.15 | $1.49 | $1.92 | -0.93% |
| Week 5 | $1.11 | $1.48 | $1.97 | -1.16% |
| Week 6 | $1.08 | $1.48 | $2.02 | -1.39% |
| Week 7 | $1.05 | $1.48 | $2.07 | -1.62% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits.
Its products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients.
The company holds a patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. It was formerly Calyxt, Inc. and changed its name to Cibus, Inc.
in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Cibus, Inc. trades under the CBUS symbol and operates in the healthcare category as an agricultural biotechnology company focused on gene-edited plant traits. The current price is $1.50 and the market cap is $121.46M, with a market ranking of 4092. These figures place CBUS among smaller-cap, niche biotech names in the market.
Forecasts show a path of earnings- and price-related variability over the coming years. The 2026 forecast averages near the current price at $1.50, with a min of $1.26 and max of $1.96 and a neutral sentiment. Longer-term projections rise gradually, with 2030 averaging $1.53 and 2040 averaging $2.71, culminating in 2050 averaging $5.21.
Each year carries its own min/max and ROI figures, including notable upside later in the horizon.
A major floor 23.6% below — a decisive break under it would weaken the trend.
The nearest floor, 14.7% below — buyers have tended to step in here.
The nearest ceiling, 6.0% above — a clean break opens room to run.
A major ceiling 170.0% above — clearing it would confirm fresh momentum.
Key CBUS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CBUS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.42 | Buy | $1.43 | Buy |
| MA 10 | $1.39 | Buy | $1.41 | Buy |
| MA 20 | $1.42 | Buy | $1.45 | Buy |
| MA 50 | $1.71 | Sell | $1.71 | Sell |
| MA 100 | $2.15 | Sell | $1.88 | Sell |
| MA 200 | $1.79 | Sell | $2.08 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.73 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 84.59 | Neutral |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.04 | Buy |
| ROC (12) | 4.17 | Buy |
| Bollinger %B (20,2) | 0.75 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -1.04 | Sell |
| Awesome (5,34) | -0.02 | Sell |
| Ultimate (7,14,28) | 65.06 | Neutral |
| Momentum (10) | 0.07 | Buy |
| Aroon Osc (25) | -32.00 | Sell |
| Hull MA (9) | 1.45 | Buy |
| ADX (14) | 18.70 | Neutral |
| ATR (14) | 0.07 | Info |
The near-term picture is neutral. RSI14 is 50, indicating balanced momentum.
The stock sits around the shorter-term moving averages, with SMA50 at $1.71 and SMA200 at $1.79. Support is noted at $1.28 and resistance at $1.59, suggesting a tight trading range ahead of longer-term movements.
Over the last 30 days, the price range has been from $1.09 to $2.06, reflecting modest volatility within a narrow band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.26 | $1.50 | $1.96 | 0% | Neutral | |
| $1.03 | $1.41 | $2.07 | -6% | Neutral | |
| $0.8338 | $1.20 | $1.86 | -20% | Bearish | |
| $0.8952 | $1.34 | $2.19 | -10% | Neutral | |
| $0.9791 | $1.53 | $2.59 | +2% | Neutral | |
| $1.16 | $1.89 | $3.29 | +26% | Bullish | |
| $1.24 | $2.09 | $3.74 | +39% | Bullish | |
| $1.03 | $1.81 | $3.32 | +20% | Bullish | |
| $0.9943 | $1.79 | $3.38 | +20% | Neutral | |
| $1.01 | $1.87 | $3.60 | +25% | Bullish | |
| $1.24 | $2.71 | $5.70 | +81% | Bullish | |
| $2.35 | $5.21 | $11.99 | +248% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.26 | $1.50 | $1.79 | +0.00% |
| June 2026 | $1.27 | $1.52 | $1.88 | +1.41% |
| July 2026 | $1.20 | $1.46 | $1.84 | -4.34% |
| August 2026 | $1.20 | $1.47 | $1.89 | +0.85% |
| September 2026 | $1.21 | $1.50 | $1.95 | +2.10% |
| October 2026 | $1.15 | $1.43 | $1.89 | -4.38% |
| November 2026 | $1.10 | $1.39 | $1.86 | -2.99% |
| December 2026 | $1.14 | $1.45 | $1.96 | +4.51% |
Click any year to see its month-by-month CBUS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Cibus, Inc.'s 2026 outlook centres on $1.50, within a $1.26 to $1.96 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, CBUS could reach as high as $2.07, with a base case around $1.41 and support toward $1.03 — roughly -6% from $1.50. A consolidation phase looks the most probable path here.
Expect CBUS to range from $0.8338 to $1.86 through 2028. The $1.20 average target implies a -20% move from current prices. That is -15% versus the projected 2027 average. A cyclical pullback looks likely — prices rarely move in a straight line.
The CBUS price prediction for 2029 points to an average of $1.34 (low $0.8952, high $2.19) — a potential decline of -10% on today's $1.50. A consolidation phase looks the most probable path here.
In 2030, CBUS is projected to trade between $0.9791 and $2.59, averaging $1.53 — a potential gain of +2% from today's $1.50. That is up +14% on the projected 2029 average. Price action looks broadly range-bound.
Cibus, Inc.'s 2031 outlook centres on $1.89, within a $1.16 to $3.29 range. That is up +23% on the projected 2030 average. That marks a +26% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, CBUS could reach as high as $3.74, with a base case around $2.09 and support toward $1.24 — roughly +39% from $1.50. Momentum favours further upside here.
Expect CBUS to range from $1.03 to $3.32 through 2033. The $1.81 average target implies a +20% move from current prices. That is -13% versus the projected 2032 average. Buyers look set to stay in control over this stretch.
The CBUS price prediction for 2034 points to an average of $1.79 (low $0.9943, high $3.38) — a potential gain of +20% on today's $1.50. Price action looks broadly range-bound.
In 2035, CBUS is projected to trade between $1.01 and $3.60, averaging $1.87 — a potential gain of +25% from today's $1.50. That is up +5% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Cibus, Inc.'s 2040 outlook centres on $2.71, within a $1.24 to $5.70 range. That is up +45% on the projected 2035 average. That marks a +81% change versus current levels. Momentum favours further upside here.
By 2050, CBUS could reach as high as $11.99, with a base case around $5.21 and support toward $2.35 — roughly +248% from $1.50. Buyers look set to stay in control over this stretch.
Investing $1,000 in CBUS today (≈ 666.666667 CBUS) could be worth
$3,475.85
+$2,475.85 (+248%) by 2050 · US Dollar
Based on the average projected CBUS price of $5.21 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CBUSwould be worth at today's price.
$1,000 invested in CBUS on May 27, 2025 (≈ 350.877205 CBUS) would be worth
$526.32
-$473.68 (-47.4%) today · 0.53× · US Dollar
Based on a CBUS entry price of $2.85 vs. today's $1.5.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.42 | $1,056.34 | +5.6% |
| 1 month ago | $1.49 | $1,006.71 | +0.7% |
| 3 months ago | $3.52 | $426.14 | -57.4% |
| 6 months ago | $1.36 | $1,102.94 | +10.3% |
| 1 year ago | $2.85 | $526.32 | -47.4% |
| All time (5.0y) ago | $219 | $6.85 | -99.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CBUS forecast.
Our base-case forecast reaches $3.00 around 2050.
Implied market cap at $3.00: $228.99M
The multi-year forecast shows a varied path, with near-term volatility and some downside in 2027–2029 (2027 ROI -6, 2028 ROI -20.2, 2029 ROI -10.4) before a more pronounced upside in the 2030s.
In 2030 the average price is projected to be $1.53 with ROI 2.1 and sentiment NEUTRAL. The following years show a progression to higher averages and stronger sentiment, including 2031 avg $1.89 (ROI 25.9, BULLISH) and 2032 avg $2.09 (ROI 39.1, BULLISH), with 2033 avg $1.81 (ROI 20.4, BULLISH) and 2034 avg $1.79 (ROI 19.6, NEUTRAL), and 2035 avg $1.87 (ROI 25, BULLISH).
Beyond 2035, the forecast envisions continued upside: 2040 avg $2.71 (ROI 80.8, BULLISH) and 2050 avg $5.21 (ROI 247.6, BULLISH). The max prices in these years reach $5.70 (2040) and $11.99 (2050). These are estimates and not guarantees, reflecting projected market dynamics and volatility over time.
Tap a question to reveal the answer.
2030 forecast: min $0.9791, avg $1.53, max $2.59; ROI 2.1; sentiment NEUTRAL.
Forecast shows mixed near-term performance (2026 avg $1.50, ROI 0; 2027 avg $1.41, ROI -6; 2028 avg $1.20, ROI -20.2; 2029 avg $1.34, ROI -10.4) but stronger upside later (2031-2050 with higher averages and bullish sentiment in several years, including 2031 avg $1.89 and 2040 avg $2.71; 2050 avg $5.21 with ROI 247.6). These are estimates and not guarantees.
Yes in the forecast: 2032 max $3.74; 2033 max $3.32; 2034 max $3.38; 2035 max $3.60. The pattern shows higher ceilings in the mid-2030s and beyond.
Current price: $1.50. Market cap: $121.46M.
2040 forecast: min $1.24, avg $2.71, max $5.70; ROI 80.8; sentiment BULLISH.
Cibus, Inc. Community Discussion
0Share your Cibus, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.